Identification of LncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Jan 4

PMID 33392203

Citations 15

Authors

Jiaqi Zhang

Hui Liu

Wenhao Zhang

Yinfang Li

Zhigang Fan

Hua Jiang

Judong Luo

Affiliations

Soon will be listed here.

Abstract

Skin cutaneous melanoma (SKCM) is an aggressive form of skin cancer that results in high mortality rate worldwide. It is vital to discover effective prognostic biomarkers and therapeutic targets for the treatment of melanoma. Long non-coding RNA (lncRNA) has been verified to play an essential role in the regulation of gene expression in diseases and tumors. Therefore, it is significant to explore the function of lncRNAs in the development and progression of SKCM. In this paper, a set of differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs) were first screened out using 471 cutaneous melanoma samples and 813 normal skin samples. Gene Ontology and KEGG pathway enrichment analysis were performed to obtain the significant function annotations and pathways of DEmRNAs. We also ran survival analysis on both DElncRNAs and DEmRNAs to identify prognostic-related lncRNAs and mRNAs. Next, a set of hub genes derived from protein-protein interaction (PPI) network analysis and lncRNA target genes screened from starbase-ENCORI database were integrated to construct a lncRNA-mRNA regulatory module, which includes 6 lncRNAs 4 target mRNAs. We further checked the capacity of these lncRNA and mRNA in the diagnosis of melanoma, and found that single lncRNA can effectively distinguish tumor and normal tissue. Moreover, we ran CMap analysis to select a list of small molecule drugs for SKCM, such as EGFR inhibitor AG-490, growth factor receptor inhibitor GW-441756 and apoptosis stimulant betulinic-acid, which have shown therapeutic effect in the treatment of melanoma.

Citing Articles

Integration of single-cell and bulk RNA sequencing data reveals that CYTOR is a potential prognostic and immunotherapeutic response marker for skin cutaneous melanoma.

Zhang M, Ju Y, Xue L, Zhao X, Xu X, Wu G J Cancer. 2024; 15(12):3890-3902.

PMID: 38911384 PMC: 11190755. DOI: 10.7150/jca.94823.

Regulatory miRNAs and lncRNAs in Skin Cancer: A Narrative Review.

Natarelli N, Boby A, Aflatooni S, Tran J, Diaz M, Taneja K Life (Basel). 2023; 13(8).

PMID: 37629553 PMC: 10455148. DOI: 10.3390/life13081696.

Identification of TUBB4A as a Prognostic Biomarker of Melanoma by Transcriptomic Data and Experiments.

Zhang J, Zhang Y, Liu J, Luo J, Yun Y, Cao Y Technol Cancer Res Treat. 2023; 22:15330338231184842.

PMID: 37439014 PMC: 10345940. DOI: 10.1177/15330338231184842.

Identification of Recurrence-Related mRNAs and Noncoding RNAs in Hepatocellular Carcinoma Following Liver Transplantation.

Zeng Q, Cao J, Niu Y, Zhao X, Wang Y, Liu W Turk J Gastroenterol. 2023; 34(4):394-405.

PMID: 37089051 PMC: 10210633. DOI: 10.5152/tjg.2023.22656.

Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies.

Xiao Y, Xia Y, Wang Y, Xue C Genes Dis. 2023; 10(1):113-125.

PMID: 37013035 PMC: 10066279. DOI: 10.1016/j.gendis.2021.08.007.

References

Somura H, Iizuka N, Tamesa T, Sakamoto K, Hamaguchi T, Tsunedomi R . A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy. Oncol Rep. 2008; 19(2):489-95. View

Tang L, Zhang W, Su B, Yu B . Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res Int. 2013; 2013:251098. PMC: 3687722. DOI: 10.1155/2013/251098. View

Gajewski T . Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res. 2007; 13(18 Pt 1):5256-61. DOI: 10.1158/1078-0432.CCR-07-0892. View

Engreitz J, Haines J, Perez E, Munson G, Chen J, Kane M . Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016; 539(7629):452-455. PMC: 6853796. DOI: 10.1038/nature20149. View

Li Z, Zhu Q, Zhang H, Hu Y, Wang G, Zhu Y . MALAT1: a potential biomarker in cancer. Cancer Manag Res. 2018; 10:6757-6768. PMC: 6289210. DOI: 10.2147/CMAR.S169406. View

Huarte M . The emerging role of lncRNAs in cancer. Nat Med. 2015; 21(11):1253-61. DOI: 10.1038/nm.3981. View

Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77. PMC: 4322527. DOI: 10.5114/wo.2014.47136. View

Sun L, Sun P, Zhou Q, Gao X, Han Q . Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140. Am J Transl Res. 2016; 8(9):3939-3946. PMC: 5040691. View

Szumera-Cieckiewicz A, Bosisio F, Teterycz P, Antoranz A, Delogu F, Koljenovic S . SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment. Eur J Cancer. 2020; 137:175-182. DOI: 10.1016/j.ejca.2020.06.037. View

10.

Li F, Li X, Qiao L, Liu W, Xu C, Wang X . MALAT1 regulates miR-34a expression in melanoma cells. Cell Death Dis. 2019; 10(6):389. PMC: 6525244. DOI: 10.1038/s41419-019-1620-3. View

11.

Zeng Y, Guo Z, Hu Z, Liu M, Chen Y, Chen S . FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function. Biomed Pharmacother. 2020; 125:110029. DOI: 10.1016/j.biopha.2020.110029. View

12.

Smoot M, Ono K, Ruscheinski J, Wang P, Ideker T . Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2010; 27(3):431-2. PMC: 3031041. DOI: 10.1093/bioinformatics/btq675. View

13.

Soura E, Eliades P, Shannon K, Stratigos A, Tsao H . Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016; 74(3):395-407. PMC: 4761105. DOI: 10.1016/j.jaad.2015.08.038. View

14.

Geisler S, Coller J . RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013; 14(11):699-712. PMC: 4852478. DOI: 10.1038/nrm3679. View

15.

Scull C, Zhang Y, Tower N, Rasmussen L, Padmalayam I, Hunter R . Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies. Biochem J. 2019; 476(15):2209-2219. PMC: 7278283. DOI: 10.1042/BCJ20190207. View

16.

Wang L, Wei C, Xu Y, Deng X, Wang Q, Ying J . Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method. Oncol Lett. 2019; 18(6):6066-6078. PMC: 6864934. DOI: 10.3892/ol.2019.10961. View

17.

Moran V, Perera R, Khalil A . Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012; 40(14):6391-400. PMC: 3413108. DOI: 10.1093/nar/gks296. View

18.

Fischer G, Gopal Y, McQuade J, Peng W, DeBerardinis R, Davies M . Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell Melanoma Res. 2017; 31(1):11-30. PMC: 5742019. DOI: 10.1111/pcmr.12661. View

19.

Luan W, Ding Y, Ma S, Ruan H, Wang J, Lu F . Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis. Cell Death Dis. 2019; 10(11):855. PMC: 6848151. DOI: 10.1038/s41419-019-2090-3. View

20.

Gao J, Zeng K, Liu Y, Gao L, Liu L . LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 2019; 12:169-179. PMC: 6309782. DOI: 10.2147/OTT.S184078. View